This topic contains a solution. Click here to go to the answer

Author Question: Staff members at the bottom of the organizational hierarchy have: A. No power. B. No power and ... (Read 34 times)

Mimi

  • Hero Member
  • *****
  • Posts: 542
Staff members at the bottom of the organizational hierarchy have:
 
  A. No power.
  B. No power and no authority.
  C. High authority and high power.
  D. Little authority, but some power.

Question 2

Which of the following is a common goal for a health-care organization?
 
  A. Survival
  B. Limited existence
  C. Cooperation with the competition
  D. Downsizing



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

ApricotDream

  • Sr. Member
  • ****
  • Posts: 336
Answer to Question 1

ANS: D

Answer to Question 2

ANS: A




Mimi

  • Member
  • Posts: 542
Reply 2 on: Jul 8, 2018
Wow, this really help


ttt030911

  • Member
  • Posts: 315
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

More than nineteen million Americans carry the factor V gene that causes blood clots, pulmonary embolism, and heart disease.

Did you know?

Cutaneous mucormycosis is a rare fungal infection that has been fatal in at least 29% of cases, and in as many as 83% of cases, depending on the patient's health prior to infection. It has occurred often after natural disasters such as tornados, and early treatment is essential.

Did you know?

About 3.2 billion people, nearly half the world population, are at risk for malaria. In 2015, there are about 214 million malaria cases and an estimated 438,000 malaria deaths.

Did you know?

Once thought to have neurofibromatosis, Joseph Merrick (also known as "the elephant man") is now, in retrospect, thought by clinical experts to have had Proteus syndrome. This endocrine disease causes continued and abnormal growth of the bones, muscles, skin, and so on and can become completely debilitating with severe deformities occurring anywhere on the body.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library